Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Top Cited Papers
- 29 August 2010
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 376 (9744), 875-885
- https://doi.org/10.1016/s0140-6736(10)61198-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003Circulation, 2009
- Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge RegistryEuropean Heart Journal, 2008
- If Inhibition with IvabradineDrug Safety, 2008
- Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMETAmerican Heart Journal, 2005
- Ventricular remodeling in heart failure and the effect of β-blockadeThe American Journal of Cardiology, 2004
- β-Blockers in Chronic Heart FailureCirculation, 2003
- Outcome of Congestive Heart Failure in Elderly Persons: Influence of Left Ventricular Systolic Function. The Cardiovascular Health Study. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) StudyCongestive Heart Failure, 2002
- Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart FailureCirculation, 2002
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- The myocardium in congestive heart failureThe American Journal of Cardiology, 1989